| Ralph H. Thurman |
Ralph H. Thurman was the founder of VIASYS Healthcare, Inc. (founded in 2001) where he served as Chairman, President & Chief Executive Officer from 2001 to 2007. He currently holds the position of Executive Chairman at ZEST Anchors LLC. Additionally, he is the Independent Executive Chairman at Outlook Therapeutics, Inc. since 2018, a Director at Pharmathen SA, a Director at Presbia USA, Inc., and a Member at Levitt Equity Partners. In his former roles, Mr. Thurman served as Chairman, President & Chief Executive Officer at SpiroTech. He was also Chairman & Chief Executive Officer at Corning Life Sciences, Inc. from 1993 to 1997, President, Chief Executive Officer & Director at Rhone-Poulenc Rorer Pharmaceuticals, Inc. from 1984 to 1993, Chairman & Chief Executive Officer at Strategic Reserves LLC from 1997 to 2001, and Chairman at Enzon Pharmaceuticals, Inc. in 2001. He held the position of Chairman at Orthofix Medical, Inc. from 2013 to 2014 and Chairman at CardioNet LLC from 2010 to 2011. He was Vice Chairman at Arno Therapeutics, Inc. from 2014 to 2015 and Executive Chairman at Presbia Holdings LLC from 2013 to 2015. He also served as Executive Chairman at Cogent HMG, Inc. from 2012 to 2014 and Executive Chairman at Presbia PLC from 2014 to 2017. Mr. Thurman has also held director positions at Bausch Health Americas, Inc. and Ikaria, Inc. He was an Independent Director at Veradigm, Inc. from 2012 to 2018 and an Independent Director at TFF Pharmaceuticals, Inc. from 2019 to 2022. He was a Partner at AEA Investors LP in 2014 and a Senior Advisor at New Mountain Capital LLC. He served as President at Rorer Group, Inc. and is a Trustee at Pamplin College of Business. Mr. Thurman's education includes an undergraduate degree from Virginia Polytechnic Institute & State University, a graduate degree from Webster University, and completion of the Air Command & Staff College program. |
| Jeff Evanson |
Jeff Evanson is the founder of Scott Three Consulting LLC, which was founded in 2018. He is currently the President of Scott Three Consulting LLC. Mr. Evanson is also currently the Chairman of Children's HeartLink, Inc., the Managing Director-Healthcare Investment Management at GMS Capital Partners LLC, and the Chief Commercial Officer at Outlook Therapeutics, Inc. Mr. Evanson's former positions include being the Managing Director-Life Science Practice at Guidehouse, Inc. (Virginia) from 2014 to 2018, the Director at Gillette Children's Specialty Healthcare from 2008 to 2014, the Director, VP & Head-Pharmaceutical at Alcon Holdings, Inc. from 2010 to 2014, and the Marketing Manager at Medtronic, Inc. from 2000 to 2010. He was also a Project Manager at Nucon Engineering Associates from 1994 to 1999. Mr. Evanson holds an MBA degree from the University of Minnesota, which he received in 2001, and an undergraduate degree from the University of St. Thomas, which he received in 1991. |
| Terry Dagnon |
Terry Dagnon is the founder of MTTR Medical LLC, which was founded in 2018. Mr. Dagnon's current jobs include being the Director at Colorado BioScience Association since 2016, the Managing Director-Healthcare Investment Management at GMS Capital Partners LLC since 2018, the Chief Operating Officer at Outlook Therapeutics, Inc. since 2018, and the Senior VP-Regulatory & Quality Operations at LSCS Holdings, Inc. Mr. Dagnon's former jobs include being the Senior Project Manager-Regulatory Affairs at Johnson & Johnson from 1997 to 1999, the Manager-Regulatory Affairs at US Oncology, Inc. from 1995 to 1997, the Senior Vice President-Operations at Eversana Life Science Services LLC from 2014 to 2018, and the Head-Regulatory Affairs at Alcon Holdings, Inc. from 1999 to 2013. Mr. Dagnon's education includes a graduate degree from San Diego State University in 2011 and an undergraduate degree from Wayland Baptist University in 1994. |
| Jennifer M. Kissner |
Jennifer M. Kissner is currently the Senior Vice President-Clinical Development at Outlook Therapeutics, Inc. Previously, she worked as the Vice President-Clinical Development at Clearside Biomedical, Inc. Dr. Kissner received her undergraduate degree from Emory University. |
| Surendra Sharma |
Surendra Sharma currently works in the medical affairs field and is currently a Senior Vice President at Outlook Therapeutics, Inc. |
| Lawrence A. Kenyon |
Lawrence A. Kenyon is currently the CFO, Secretary, Treasurer & Director at Outlook Therapeutics, Inc. He previously held positions as President, CEO, CFO & Secretary at Tamir Biotechnology, Inc. from 2011 to 2013, Director at Tamir Biotechnology, Inc. in 2007, Chief Financial Officer & Executive Vice President at Endo Generics Holdings, Inc. from 2008 to 2010, Chief Financial Officer, Secretary & EVP at NeoPharm, Inc. from 2000 to 2006, Chief Financial Officer at Par Pharmaceutical, Inc. from 2008 to 2010, and Chief Operating & Financial Officer at Arno Therapeutics, Inc. from 2014 to 2015. Mr. Kenyon obtained his undergraduate degree from the University of Wisconsin in 1987. |
| C. Russell Trenary |
C. Russell Trenary is currently the President, Chief Executive Officer & Director at Outlook Therapeutics, Inc. since 2021. He is also a Director at InnFocus, Inc. since 2013. Previously, he served as the President & Chief Executive Officer at Sunrise Technologies International, Inc. from 1996 to 2001. He was also the President & Chief Executive Officer at G&H Wire Co., Inc. He worked at Allergan, Inc. as the Senior Vice President & GM-AMO Surgical Products from 1987 to 1995. Additionally, he held the position of Senior Vice President-Worldwide Sales & Marketing at VidaMed, Inc. from 1995 to 1996. From 2002 to 2009, he was the EVP-Global Public Policy & Medical Education at Advanced Medical Optics, Inc. Mr. Trenary holds an MBA from Michigan State University and an undergraduate degree from Miami University. |
| Andong Huang |
Andong Huang has worked as an Independent Director at Outlook Therapeutics, Inc. since 2020. He also holds a position as President of the Chinese Undergraduate Association at the University of Toronto, which is his current job. |
| Yazan Mndir Jeris Haddadin |
Yazan Mndir Jeris Haddadin is currently the Chief Executive Officer at GMS Capital Partners LLC, an Independent Non-Executive Director at Jordan Ahli Bank, and an Independent Director at Outlook Therapeutics, Inc. He is also a Member of the New York State Bar Association and the Aspen Global Leadership Network. Previously, he worked as an Executive Director in the M&A Group at JPMorgan Chase & Co. and as a Managing Director at Perella Weinberg Partners Group LP. He also served as a Non-Executive Director at Six of October Development & Investment (SODIC), Director at Near East Foundation, Chief Investment Officer at Capital Bank of Jordan, and Principal at Perella Weinberg Partners LP. Mr. Haddadin holds a graduate degree from Northwestern University School of Law and an undergraduate degree from Georgetown University in Qatar. |
| Julian S. Gangolli |
Julian S. Gangolli is an Independent Director at Revance Therapeutics, Inc. since 2016, Outlook Therapeutics, Inc. since 2020, and Krystal Biotech, Inc. since 2019. He previously worked as a Director at the National Society to Prevent Blindness. From 1998 to 2015, he was the President-North American Pharmaceutical Division at Allergan, Inc. He also served as the Vice President-Sales & Marketing at VIVUS, Inc. from 1994 to 1998. In 2004, he briefly held the position of Senior Vice President at Medical Management of America, Inc. From 2015 to 2019, he was the President-North America Region at Greenwich Biosciences, Inc. and GW Pharmaceuticals Ltd. Mr. Gangolli completed his undergraduate degree at Kingston University in 1981. |
| Kurt J. Hilzinger |
Kurt J. Hilzinger is currently serving as the Chairman at Humana, Inc. He is also a Director at National Seating & Mobility, Inc., Letco, Inc., Celerion, Inc., Outlook Therapeutics, Inc., Integrated Prescription Management, Inc., NDC, Inc., JKC Parent, Inc., Claritas Rx LLC, and a Partner at Court Square Capital Partners. Previously, he held the position of Chairman at Healthcare Distribution Alliance from 2000 to 2007 and served as the President, Chief Operating Officer & Director at Cencora, Inc. from 1997 to 2007. Mr. Hilzinger completed his undergraduate degree from the University of Michigan in 1983. |
| Faisal Ghiath Munir Sukhtian |
Faisal Ghiath Munir Sukhtian is currently the Director at Expert Petroleum SRL, Independent Director at Outlook Therapeutics, Inc., Director at Munir Sukhtian Pharmaceuticals, and Executive Director at GMS Holdings. He previously held positions as Director at Waterloo Industries, Inc., Alvogen, Inc., and Munir Sukhtian International. He was also the Managing Director & Director at Agri Sciences Ltd. Mr. Sukhtian has an MBA from Columbia Business School and an undergraduate degree from Georgetown University in Qatar. |
| Gerd U. Auffarth |
Gerd U. Auffarth is currently the Chief Executive Officer at Steinbeis-transferzentrum. He is also the Chairman of the Ophthalmology Department at Ruprecht-Karls-Universität Heidelberg. Additionally, he serves as the Director of The European Society of Cataract & Refractive Surgeons, the Independent Director at Outlook Therapeutics, Inc., and the Director of the International Vision Correction Research Centre, the David J Apple International Laboratory For Ocular Pathology, the German Ophthalmological Society, and the Deutschsprachige Gesellschaft Fur Intraokularlinsen. Previously, he worked as an Independent Director at Presbia PLC. Dr. Auffarth obtained his doctorate degree from RWTH Aachen University in 1990 and also holds a doctorate degree from Ruprecht-Karls-Universität Heidelberg. |
| Jöerg Windisch |
Presently, Jöerg Windisch occupies the position of Chief Operating Officer of Polpharma Biologics. He is also on the board of Outlook Therapeutics, Inc.
In the past Dr. Windisch occupied the position of Chief Operating Officer at Affimed NV and Chief Science Officer at Sandoz International GmbH.
Dr. Windisch received a doctorate from the University of Innsbruck. |
| Julia A. Haller |
Julia A. Haller is currently the Chairman of the Ophthalmology Department & Professor at Sidney Kimmel Medical College. She is also the Chairman at The College of Physicians of Philadelphia. Additionally, she serves as an Independent Director at Bristol Myers Squibb Co., an Independent Non-Executive Director at Opthea Ltd., a Director at Kimmel Center, Inc., a Director at The Philadelphia Orchestra Association, and a Director at the Association of University Professors of Ophthalmology. Dr. Haller is also an Independent Director at Outlook Therapeutics, Inc. and the President & Director of The Johns Hopkins Medical & Surgical Association. She is a Director at The Society of Heed Fellows and a Professor at Thomas Jefferson University Hospital. Furthermore, she holds the position of Treasurer at Macula Society. Previously, Dr. Haller served as the Ophthalmologist-in-Chief at Wills Eye Health System & Wills Eye Institute. She was also a Member of the National Academy of Medicine and a Member-Governors Board at ARVO Foundation for Eye Research. Dr. Haller is the former Independent Director at Celgene Corp. and the former Independent Director at Eyenovia, Inc. She was a Trustee at Princeton University and the Chief Resident at Wilmer Eye Institute. Dr. Haller has also worked as a Professor at The Johns Hopkins University School of Medicine. In terms of education, she completed her undergraduate degree at Princeton University and obtained her doctorate from Harvard Medical School. |
